Dr. Ryan Meyer, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 200 Ne Mother Joseph Pl Ste 100, Vancouver, WA 98664 Phone: 360-514-3142 Fax: 360-514-6809 |
David Helde, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr, Suite 246, Vancouver, WA 98684 Phone: 360-696-1070 Fax: 360-737-0200 |
Laurie A Cardoza, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr, Suite 246, Vancouver, WA 98684 Phone: 360-696-1070 Fax: 360-737-0200 |
Tracy Lee Thomas, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr, Suite 246, Vancouver, WA 98684 Phone: 360-696-1070 Fax: 360-737-0200 |
Chelsea Elizabeth Ann Frazier, LMP Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 11815 Ne Highway 99, Suite A, Vancouver, WA 98686 Phone: 360-696-4405 Fax: 360-696-0582 |
David Impastato, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl Ste 300, Vancouver, WA 98664 Phone: 360-254-6161 |
Dr. John P Kafrouni, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 200 Ne Mother Joseph Pl, Suite 210, Vancouver, WA 98664 Phone: 360-254-6161 Fax: 360-449-1139 |
Dr. Robert S. Djergaian, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 200 Ne Mother Joseph Pl Ste 100, Vancouver, WA 98664 Phone: 360-514-3142 |
Dong Pil Kim, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 700 Ne 87th Ave, Vancouver, WA 98664 Phone: 360-254-1240 Fax: 360-397-3128 |
Ms. Karen L Savory, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 201 Ne Park Plaza Dr Ste 246, Vancouver, WA 98684 Phone: 360-696-1070 |
News Archive
Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.
Chemicals in pharmaceutical drugs can obviously save lives. But as more and stronger chemicals have been introduced, our basic knowledge of the broader health impact of all these chemicals has not kept up with the rapid pace of innovation. There is exceptionally little information on how chemicals in our drugs and also in the environment around us, including on the food we eat, impact some of the most important cells in our body: stem cells. Without basic knowledge and tests on the impact of chemicals on our stem cells, we may be unwittingly damaging essential regenerative functions in our body.
In a new study published in Circulation Research, Chen-Yu Zhang and Xiaohong Jiang's group from Nanjing University and Dongjin Wang's group from Nanjing Drum Tower Hospital reported a critical role of PGC1α in maintaining the contractile phenotype of vascular smooth muscle cells (VSMCs) and highlighted the therapeutic potential of PGC1α for atherosclerosis.
Political intimidation has always been part of the current Congress's health-care strategy: "If you're not at the table, you're on the menu" is tattooed on every lobbyist and industry rep in Washington. But Max Baucus's latest bullying tactics are hard to believe by even these standards, as the Senate Finance Chairman has sicced federal regulators on the insurer Humana Inc. for daring to criticize one part of his health bill (9/22).
The Association for Molecular Pathology (AMP) provided comments at the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) meeting on October 8. AMP opposes the patenting of all naturally occurring genetic material and has signed on as a lead plaintiff in the ACLU case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes. AMP thanked SACGHS for studying how both patents and restrictive licensing limit patient access and potentially reduce the quality of tests.
› Verified 3 days ago